Literature DB >> 32649236

Differentiation of salivary gland tumor using diffusion-weighted imaging with a fractional order calculus model.

Wei Chen1, Liu-Ning Zhu2, Yong-Ming Dai3, Jia-Suo Jiang1, Shou-Shan Bu2, Xiao-Quan Xu1, Fei-Yun Wu1.   

Abstract

OBJECTIVE: To evaluate the feasibility of using imaging parameters (D, β and μ) obtained from fractional order calculus (FROC) diffusion model to differentiate salivary gland tumors.
METHODS: 15 b-value (0-2000 s/mm2) diffusion-weighted imaging (DWI) was scanned in 62 patients with salivary gland tumors (47 benign and 15 malignant). Diffusion coefficient D, fractional order parameter β (which correlates with tissue heterogeneity) and a microstructural quantity μ of the solid portion within the tumor were calculated, and compared between benign and malignant groups, or among pleomorphic adenoma (PA), Warthin's tumor (WT), and malignant tumor (MT) groups. Performance of FROC parameters for differentiation was assessed using receiver operating characteristic analysis.
RESULTS: None of the FROC parameters exhibited significant differences between benign and malignant group (D, p = 0.150; β, p = 0.967; μ, p = 0.693). WT showed significantly lower D (p < 0.001) and β (p < 0.001), while higher μ (p = 0.001) than PA. Combination of D, β and μ showed optimal diagnostic performance (area under the curve, AUC, 0.998). MT showed significantly lower D (p = 0.001) and β (p = 0.025) than PA, while no significant difference was found on μ (p = 0.064). Combination of D and β showed optimal diagnostic performance (AUC, 0.933). Significant difference was found on β (p = 0.027) between MT and WT, while not on D (p = 0.806) and μ (p = 0.789). Setting a βof 0.615 as the cut-off value, optimal diagnostic performance could be obtained (AUC = 0.806).
CONCLUSION: A non-Gaussian FROC diffusion model can serve as a noninvasive and quantitative imaging technique for differentiating salivary gland tumors. ADVANCES IN KNOWLEDGE: (1) PA showed higher D and β and lower μ than WT. (2) PA had higher D and β than MT. (3) WT demonstrated lower β than MT. (4) β, as a new FROC parameter, could offer an added value to the differentiation.

Entities:  

Mesh:

Year:  2020        PMID: 32649236      PMCID: PMC7465841          DOI: 10.1259/bjr.20200052

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  24 in total

1.  Anomalous diffusion expressed through fractional order differential operators in the Bloch-Torrey equation.

Authors:  Richard L Magin; Osama Abdullah; Dumitru Baleanu; Xiaohong Joe Zhou
Journal:  J Magn Reson       Date:  2007-11-13       Impact factor: 2.229

2.  Breast Cancer: Diffusion Kurtosis MR Imaging-Diagnostic Accuracy and Correlation with Clinical-Pathologic Factors.

Authors:  Kun Sun; Xiaosong Chen; Weimin Chai; Xiaochun Fei; Caixia Fu; Xu Yan; Ying Zhan; Kemin Chen; Kunwei Shen; Fuhua Yan
Journal:  Radiology       Date:  2015-05-04       Impact factor: 11.105

3.  Histogram analysis of apparent diffusion coefficient maps for differentiating malignant from benign parotid gland tumors.

Authors:  Gao Ma; Liu-Ning Zhu; Guo-Yi Su; Hao Hu; Wen Qian; Shou-Shan Bu; Xiao-Quan Xu; Fei-Yun Wu
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-02       Impact factor: 2.503

4.  Differentiation of Low- and High-Grade Pediatric Brain Tumors with High b-Value Diffusion-weighted MR Imaging and a Fractional Order Calculus Model.

Authors:  Yi Sui; He Wang; Guanzhong Liu; Frederick W Damen; Christian Wanamaker; Yuhua Li; Xiaohong Joe Zhou
Journal:  Radiology       Date:  2015-06-02       Impact factor: 11.105

5.  Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors.

Authors:  Misa Sumi; Marc Van Cauteren; Tadateru Sumi; Makoto Obara; Yoko Ichikawa; Takashi Nakamura
Journal:  Radiology       Date:  2012-03-23       Impact factor: 11.105

6.  Multimodality fMRI with perfusion, diffusion-weighted MRI and 1 H-MRS in the diagnosis of lympho-associated benign and malignant lesions of the parotid gland.

Authors:  Ling Zhu; Jingbo Wang; Huimin Shi; Xiaofeng Tao
Journal:  J Magn Reson Imaging       Date:  2018-11-26       Impact factor: 4.813

7.  Differentiating benign and malignant salivary gland tumours: diagnostic criteria and the accuracy of dynamic contrast-enhanced MRI with high temporal resolution.

Authors:  P D Lam; A Kuribayashi; A Imaizumi; J Sakamoto; Y Sumi; N Yoshino; T Kurabayashi
Journal:  Br J Radiol       Date:  2015-03-20       Impact factor: 3.039

8.  Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

Authors:  C R Habermann; C Arndt; J Graessner; L Diestel; K U Petersen; F Reitmeier; J O Ussmueller; G Adam; M Jaehne
Journal:  AJNR Am J Neuroradiol       Date:  2009-01-08       Impact factor: 3.825

9.  Malignant parotid tumors: clinical use of MR imaging and histologic correlation.

Authors:  N J Freling; W M Molenaar; A Vermey; E L Mooyaart; A K Panders; A A Annyas; C J Thijn
Journal:  Radiology       Date:  1992-12       Impact factor: 11.105

10.  Value of diffusion tensor imaging in differentiating malignant from benign parotid gland tumors.

Authors:  Koji Takumi; Yoshihiko Fukukura; Hiroto Hakamada; Junichi Ideue; Yuichi Kumagae; Takashi Yoshiura
Journal:  Eur J Radiol       Date:  2017-08-18       Impact factor: 3.528

View more
  1 in total

1.  A comparison study of monoexponential and fractional order calculus diffusion models and 18F-FDG PET in differentiating benign and malignant solitary pulmonary lesions and their pathological types.

Authors:  Yu Luo; Han Jiang; Nan Meng; Zhun Huang; Ziqiang Li; Pengyang Feng; Ting Fang; Fangfang Fu; Jianmin Yuan; Zhe Wang; Yang Yang; Meiyun Wang
Journal:  Front Oncol       Date:  2022-07-21       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.